Related Experiment Videos
[Pulmonary arteriovenous malformations and fistulas]
J T Lund1, M B Jensen, P Lauridsen
1Thoraxkirurgisk afdeling RT, Rigshospitalet, København.
Ugeskrift for Laeger
|April 13, 1992
Summary
Pulmonary arteriovenous malformations (PAVMs), often linked to Rendu-Osler-Weber syndrome, pose serious risks. Active therapy is recommended for PAVMs, with embolotherapy as a promising alternative for widespread cases.
Area of Science:
- Vascular Medicine
- Interventional Radiology
Context:
- Pulmonary arteriovenous malformations (PAVMs) are abnormal connections between pulmonary arteries and veins.
- PAVMs are frequently associated with hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, in 40-65% of cases.
- These malformations carry a significant risk of severe complications, particularly neurological events.
Purpose:
- To review the management of pulmonary arteriovenous malformations.
- To highlight the risks associated with PAVMs, including cerebral complications.
- To evaluate treatment options, including surgery and embolotherapy.
Summary:
- Operative treatment for PAVMs can reduce morbidity and mortality but poses challenges in complex cases with multiple or bilateral lesions.
- Embolotherapy is presented as a viable and promising alternative to surgery, especially for patients with extensive or widespread PAVMs.
- The literature supports active treatment for all patients diagnosed with PAVMs and fistulas.
Impact:
- Active therapeutic intervention is crucial for managing PAVMs to prevent serious complications.
- Embolotherapy offers a less invasive option for complex PAVM cases, potentially improving patient outcomes.
- The recommendation for active therapy underscores the importance of timely and appropriate management of PAVMs, except in select asymptomatic cases.